Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin
Palabras clave : 
Gentamicin
Nanoparticles
Intracellular bacteria
Drug accumulation
Subcellular distribution
Fecha de publicación : 
2012
Editorial : 
Oxford University Press
ISSN : 
0305-7453
Cita: 
Imbuluzqueta E, Lemaire S, Gamazo C, Elizondo E, Ventosa N, Veciana J, et al. Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin. J Antimicrob Chemother 2012 Sep;67(9):2158-2164.
Resumen
OBJECTIVES: The aim of this study was to investigate different hydrophobic gentamicin formulations [gentamicin-bis(2-ethylhexyl) sulfosuccinate (GEN-AOT), microstructured GEN-AOT (PCA GEN-AOT) and GEN-AOT-loaded poly(lactide-co-glycolide) acid (PLGA) nanoparticles (NPs)] in view of improving its therapeutic index against intracellular bacteria. The intracellular accumulation, subcellular distribution and intracellular activity of GEN-AOT and NPs in different monocytic-macrophagic cell lines were studied. METHODS: Human THP-1 and murine J774 phagocytic cells were incubated with GEN-AOT formulations at relevant extracellular concentrations [from 1× MIC to 18 mg/L (human C(max))], and their intracellular accumulation, subcellular distribution and toxicity were evaluated and compared with those of conventional unmodified gentamicin. Intracellular activity of the formulations was determined against bacteria showing different subcellular localizations, namely Staphylococcus aureus (phagolysosomes) and Listeria monocytogenes (cytosol). RESULTS: GEN-AOT formulations accumulated 2-fold (GEN-AOT) to 8-fold (GEN-AOT NPs) more than gentamicin in phagocytic cells, with a predominant subcellular localization in the soluble fraction (cytosol) and with no significant cellular toxicity. NP formulations allowed gentamicin to exert its intracellular activity after shorter incubation times and/or at lower concentrations. With an extracellular concentration of 10× MIC, a 1 log(10) decrease in S. aureus intracellular inoculum was obtained after 12 h instead of 24 h for NPs versus free gentamicin, and a static effect was observed against L. monocytogenes at 24 h with NPs, while free gentamicin was ineffective. CONCLUSIONS: GEN-AOT formulations yielded a high cellular accumulation, especially in the cytosol, which resulted in improved efficacy against both intracellular S. aureus and L. monocytogenes.

Ficheros en este ítem:
Vista previa
Fichero
Imbuluzqueta-et-al-Manuscript-JAC-2011-1250R1.pdf
Descripción
Tamaño
483.19 kB
Formato
Adobe PDF
Vista previa
Fichero
Figure1-JAC-2011-1250R1.pdf
Descripción
Tamaño
209.21 kB
Formato
Adobe PDF
Vista previa
Fichero
Figure2-JAC-2011-1250R1.pdf
Descripción
Tamaño
109.92 kB
Formato
Adobe PDF
Vista previa
Fichero
Figure3-JAC-2011-1250R1.pdf
Descripción
Tamaño
344.73 kB
Formato
Adobe PDF
Vista previa
Fichero
FigureS1-JAC-2011-1250R1.pdf
Descripción
Tamaño
128.98 kB
Formato
Adobe PDF
Vista previa
Fichero
FigureS2-JAC-2011-1250R1.pdf
Descripción
Tamaño
117.38 kB
Formato
Adobe PDF
Vista previa
Fichero
FigureS3-JAC-2011-1250R1.pdf
Descripción
Tamaño
58.67 kB
Formato
Adobe PDF
Vista previa
Fichero
Table S1.pdf
Descripción
Tamaño
25.5 kB
Formato
Adobe PDF


Estadísticas e impacto
0 citas en
0 citas en

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.